Queensland Life Sciences Industry Report 2012 (PDF, 3.5MB)

More documents

Recommendations

Info

Queensland Life Sciences Industry Report 2012 50 According to the BioSpectrum Asia-Pacific Industry Survey, the Asia-Pacific region did not experience the same contraction in R&D expenditure as the listed Biotechnology sectors in the USA, Europe, Canada and Australia. The survey, which included Australia-New Zealand, China, India, Malaysia, Singapore, South Korea and Taiwan, reported that the average R&D expenditure in the Asia Pacific region in 2010 was 12.34% of total expenditure, compared to 9.44% in 2009. 64 By comparison, in 2011, R&D expenditure reported by QLS companies was 9% of total expenditure. In 2009, this figure was 13%. 7.5.1 Business Expenditure on R&D (BERD) The average BERD across OECD countries in 2008/2009 was 1.62% of GDP. Australia was ranked 14th (out of 34) in the OECD rankings in 2008/2009 ahead of the UK, Canada and New Zealand. Figures for 2009/2010 were not available. An analysis of those countries that reported 2009/2010 BERD data revealed that Israel led the OECD countries (3.42% of GDP), followed by Finland (2.83% of GDP), Sweden (2.55% of GDP), and Japan (2.53% of GDP). 65 Between 2005/2006 and 2008/2009 the OECD average BERD as a percentage of GDP grew, with a CAGR of 1.46% (Figure 17). Over the same period Australian BERD as a percentage of GDP grew with a CAGR of 8.45%. However, for the first time in a decade, Australian BERD dropped in 2009/2010. Australian BERD totalled $16.7 billion or 1.30% of GDP in FY2010, $579 million less than FY2009 (1.38% GDP) — a 3.35% decline in actual figures and a 6% decline in BERD as a proportion of GDP. 66 Figure 17: Business expenditure on R&D as a percentage of GDP 2004 – 2010 67 The reduction in BERD did not occur uniformly across businesses of all sizes. 68 Businesses with over 200 employees accounted for the majority of total BERD (69%) in 2009/2010 and experienced the greatest reduction in R&D expenditure between 2008/2009 and 2009/2010 (5%). Businesses employing between 20–199 employees accounted for 19% of BERD and experienced a 0.5% increase. Those businesses employing between 5-19 staff accounted for 9% of BERD and reported a decrease of 4%. The smallest businesses, 0–4 staff, registered an 8% increase in BERD but accounted for only 4% of total BERD in 2009/2010. ABS figures suggest that from 2007 to 2010, Queensland businesses accounted for an average of 14.2% of total national BERD (Figure 18). Queensland BERD as a percentage of the national total was 13.6% in 2007 and 14.1% in 2010. Figure 18: Business expenditure on R&D, Queensland vs. Australia 2007 – 2010 69 In comparison with other Australian states, Queensland ranked fourth in terms of total BERD in FY2010 (Figure 19). Figure 19: Business expenditure on R&D Queensland vs. other states, 2009/201070 Figure 20 compares Queensland and other Australian States in terms of their BERD in professional, scientific and technical industries in FY2010. 64 BioSpectrum Asia-Pacific Life Sciences Industry Survey 2009 and 2010, www.biospectrumasia.com 65 OECD Science, Technology and Industry Scoreboard 2011 66 Australian Bureau of Statistics 8104.0 - Research and Experimental Development, Businesses, Australia, 2009-10 67 Australian Bureau of Statistics, 8104.0 Research and Experimental Development, Business Australia, 2009-20010 68 Ibid. 69 Australian Bureau of Statistics, 8104.0 Research and Experimental Development, Business Australia, 2009/2010 70 Australian Bureau of Statistics, 8104.0 Research and Experimental Development, Business Australia, 2009/2010. 71 Australian Bureau of Statistics, 8104.0 Research and Experimental Development, Business Australia, 2009/2010.
Figure 20: Business expenditure on professional, scientific and technical R&D in Queensland vs. other states, FY201071 7.5.2 Government Expenditure on R&D (GOVERD) Government expenditure on R&D (GOVERD) may be used as a proxy for assessing government investment in innovation. 72 Based on ABS data, between 2006/2007 and 2008/2009 Australian GOVERD increased by 10% in real terms but as a proportion of GDP it dropped slightly from 0.28% to 0.27%. Despite this, Australia’s GOVERD/GDP ratio remained close to the OECD average of 0.26% in FY2008 (data for subsequent years is not available). In FY2008, Australia ranked tenth in the OECD for GOVERD as a proportion of GDP. Iceland, Korea and Germany were the top three countries. In 2008/2009, 13% of GOVERD was directed to health and medical research. ABS data indicated that in FY2009 the Australian and State Governments spent a total of $3.42 billion on R&D including $0.48 billion in Queensland. 73 The dollar value of GOVERD increased in Queensland between FY2005 and FY2009 (Figure 21). Figure 21: Government expenditure on R&D, by state, 2005 – 2009 72 Commonwealth Department of Innovation, Industry, Science and Research, (2011) ‘Australian Innovation System Report 2011’. http://www.innovation.gov.au/ Innovation/Policy/Pages/AustralianInnovationSystemReport.aspx 73 Australian Bureau of Statistics, 8109.0 - Research and Experimental Development, Government and Private Non-Profit Organisations, Australia, 2008–2009. 51
Page 1 and 2: Queensland Life Sciences Industry R
Page 3 and 4: Since VenturePro was established in
Page 5 and 6: Strata were defined by industry (TM
Page 7 and 8: TABLE OF CONTENTS IMPORTANT NOTICE
Page 9 and 10: Queensland’s listed Life Sciences
Page 20: Queensland Life Sciences Industry R
Page 33 and 34: 5.2 Total Estimated Life Sciences I
Page 35 and 36: TABLE 22: IBISWorld industry statis
Page 37 and 38: TABLE 28: Wage and Salary Expenditu
Page 39 and 40: Research organisations reported tha
Page 65 and 66: 10.2 Finance 10.2.1 Debt and Equity
Page 67 and 68: Figure 33: Number of patent applica
Page 69 and 70: By Anne-Marie Birkill, Partner at O
Page 71 and 72: 11.1.2 Contract Manufacturing Half
Page 73 and 74: Figure 43: Importance of Queensland

Queensland Life Sciences Industry Report 2012 (PDF, 3.5MB)

Create successful ePaper yourself

Delete template?

Save as template?